CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Operator Experience and Outcomes After Left Main Percutaneous Coronary Intervention Modifiable lifestyle factors and heart failure: A Mendelian randomization study The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus From Focal Lipid Storage to Systemic Inflammation Primary Prevention of Heart Failure in Women From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement Metabolic Interactions and Differences between Coronary Heart Disease and Diabetes Mellitus: A Pilot Study on Biomarker Determination and Pathogenesis Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?

Clinical Trial2020 Nov 11.

JOURNAL:Circulation. Article Link

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial

SD Anker, J Butler, EMPEROR-Reduced Trial Committees and Investigators et al. Keywords: cardiorenal outcomes; empagliflozin

Full Text PDF